View JosephJimenez, Chief Executive Officer at Novartis, executive profile on Equilar Atlas to see current salary at Novartis and compensation history from Heinz H. J., ASTRAZENECA PLC and Pinnacle Foods Finance LLC, including insider transactions, and gain access to JosephJimenez network of 246 business contacts.
Mr. JosephJimenez, also known as Joe, MBA has been the Chief Executive Officer of Novartis AG since February 1, 2010. Mr. Jimenez serves as the Chief Executive Officer of Novartis International AG. He serves as the Chief Executive of Global …s Business at Novartis Corporation. He serve
14.08.2008 by EU Politics Today: EU Financial News ... SPEEDEL SHAREHOLDERS ELECT FOUR NOVARTIS OFFICERS AS NEW MEMBERS ... a three years term: * Dr. Raymund Breu - Chief Financial Officer, Novartis International * JosephJimenez - ...
July 19 (Bloomberg) -- JosephJimenez, chief executive officer of Novartis AG, talks about the company's second-quarter profit reported today and acquisition strategy. He speaks... - 07.19.2011, Bloomberg
23.11.2011 [IEWY News] - “For over a decade, Novartis has engaged in the front ranks of combating malaria, pioneering the not-for-profit supply of our antimalarial treatment Coartem® to the public sector of endemic countries,” commented JosephJimenez, CEO of Novartis.
16.07.2009 Novartis Pharma CEO Sees Diovan Sales Of Above $2B In 2014 Wall Street Journal ZURICH (Dow Jones)–Swiss drugmaker Novartis AG (NVS) expects sales of its best-selling drug Diovan to top $2 billion in 2014, JosephJimenez, … and more » ...
Big Pharma companies have hit a wall chasing billion-dollar drugs. Novartis CEO JosephJimenez outlines a new paradigm for blockbuster medications. FORTUNE -- Big Pharma is still big, but its business model is dying.